Investment analysts at StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the technology company’s stock.
Separately, HC Wainwright lowered their price objective on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating for the company in a research note on Monday, June 10th.
Read Our Latest Stock Report on Applied DNA Sciences
Applied DNA Sciences Price Performance
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last announced its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.60) by ($0.71). Applied DNA Sciences had a negative net margin of 222.33% and a negative return on equity of 306.32%. The company had revenue of $0.93 million for the quarter, compared to analysts’ expectations of $0.90 million. Equities research analysts expect that Applied DNA Sciences will post -2.95 EPS for the current fiscal year.
Institutional Trading of Applied DNA Sciences
An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC purchased a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is owned by hedge funds and other institutional investors.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- What is the Australian Securities Exchange (ASX)
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- How to Invest in Blue Chip Stocks
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.